Cerebral blindness and encephalopathy with cyclosporin A toxicity
- 1 June 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 37 (6) , 1072
- https://doi.org/10.1212/wnl.37.6.1072
Abstract
We observed acute cerebral blindness and encephalopathy complicating cyclosporin A (Cy A) toxicity in a 5-year-old transplantation patient. Serum CyA level was 1,704 ng/ml (normal, <300 ng/ml). Additional neurologic complications of CyA toxicity will be reviewed.This publication has 10 references indexed in Scilit:
- THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTSThe Lancet, 1985
- Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft‐versus‐host disease prophylaxisBritish Journal of Haematology, 1985
- Evaluation of cyclosporin‐phenytoin interaction with observations on cyclosporin metabolites.British Journal of Clinical Pharmacology, 1984
- ASSOCIATION BETWEEN CYCLOSPORIN NEUROTOXICITY AND HYPOMAGNESAEMIAThe Lancet, 1984
- ADULT RESPIRATORY DISTRESS SYNDROME AND CONVULSIONS ASSOCIATED WITH AMINISTRATION OF CYCLOSPORINE IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1984
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1984
- Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.BMJ, 1982
- CYCLOSPORIN-A - INDUCED INCREASES IN RENIN STORAGE AND RELEASE1982
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Neurological Aspects of Magnesium MetabolismArchives of Neurology, 1965